News Quantified

CPIX – cumberland pharmaceuticals inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Cumberland Pharmaceuticals (NASDAQ:CPIX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Cumberland Pharmaceuticals (NASDAQ:CPIX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH [Yahoo! Finance]

CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q3 2025 FINANCIAL RESULTS & COMPANY UPDATE

Form 4 CUMBERLAND PHARMACEUTICA For: Nov 03 Filed by: Young Caroline

Form 4 CUMBERLAND PHARMACEUTICA For: Nov 03 Filed by: Jones James

Form 4 CUMBERLAND PHARMACEUTICA For: Nov 03 Filed by: Krogulski Kenneth

Form 4 CUMBERLAND PHARMACEUTICA For: Nov 03 Filed by: KAZIMI A J

Form 8-K CUMBERLAND PHARMACEUTICA For: Nov 18

Top News Gainers

9/10 Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 17.0%

3/4 Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2019 Financial Results 15.9%

5/7 Cumberland Pharmaceuticals To Announce First Quarter 2019 Financial Results 13.3%

12/2 Cumberland Pharmaceuticals Receives FDA Approval for RediTrex™ Product Line 9.3%

4/7 To Help Prepare for the COVID-19 Patient Surge Cumberland Pharmaceuticals Expands Availability of Vaprisol® to Treat Hyponatremia in Critical Care Units 8.1%

5/15 Form 10-Q CUMBERLAND PHARMACEUTICA For: Mar 31 7.1%

11/19 Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) had its price target lowered by analysts at B. Riley from $12.25 to $9.00. They now have a "buy" rating on the stock. 5.2%

9/27 Form 8-K CUMBERLAND PHARMACEUTICA For: Sep 27 5.1%

5/17 Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $7.00 price target on the stock. 4.6%

5/14 Q1/2019 3/31/2019 EPS 0.110 ZacksConsensus -0.110 ActVsEst 0.220 - Beat 4.1%

Top News Decliners

11/12 Q3/2019 9/30/2019 EPS 0.010 ZacksConsensus 0.090 ActVsEst (0.080) - Miss -13.6%

9/10 Form 8-K CUMBERLAND PHARMACEUTICA For: Sep 10 -6.8%

8/30 Form 4 CUMBERLAND PHARMACEUTICA For: Aug 23 Filed by: Bernard Gordon R -6.7%

12/3 Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) had its price target raised by analysts at B. Riley from $9.00 to $9.75. They now have a "buy" rating on the stock. -5.0%

1/7 Cumberland Pharmaceuticals Announces The National Launch Of A New Caldolor Ready-To-Use Product -4.1%

5/14 Form 8-K CUMBERLAND PHARMACEUTICA For: May 14 -4.1%

8/16 Form 4 CUMBERLAND PHARMACEUTICA For: Aug 01 Filed by: Bernard Gordon R -3.9%

3/20 Form 10-K CUMBERLAND PHARMACEUTICA For: Dec 31 -3.8%

9/24 Cumberland Pharmaceuticals Announces FDA Orphan Drug Grant Award For New Phase II Clinical Program -3.6%

1/3 Form 8-K CUMBERLAND PHARMACEUTICA For: Jan 03 -3.6%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day